Pacer Advisors, Inc. Akero Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$18.31 - $24.62 $12,395 - $16,667	-677 Reduced 49.6%	688 $16,000
Q1 2024 May 10, 2024	BUY	$17.76 - $31.18 $24,242 - $42,560	1,365 New	1,365 $34,000
Q2 2021 Jul 21, 2021	SELL	$24.81 - $32.35 $25,653 - $33,449	-1,034 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$24.04 - $34.19 $5,192 - $7,385	-216 Reduced 17.28%	1,034 $30,000
Q4 2020 Jan 20, 2021	BUY	$25.12 - $29.89 $31,400 - $37,362	1,250 New	1,250 $32,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.45B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.